A double- blind, randomized, and placebo-controlled clinical trial with omega-3 polyunsaturated fatty acids (OPFA ɷ-3) for the prevention of migraine in chronic migraine patients using amitriptyline-Reference-Cited by-同舟云学术

A double- blind, randomized, and placebo-controlled clinical trial with omega-3 polyunsaturated fatty acids (OPFA ɷ-3) for the prevention of migraine in chronic migraine patients using amitriptyline

Published:2017-01-05 Issue:3 Volume:21 Page:219-223
ISSN:1028-415X
Container-title:Nutritional Neuroscience
language:en
Short-container-title:Nutritional Neuroscience

Author:

Soares Adriana de Almeida¹,Louçana Polyanna Mendes Camarço¹,Nasi Ema Pereira²,Sousa Kamila Maria de Holanda²,Sá Odara Maria de Sousa³,Silva-Néto Raimundo Pereira⁴

Affiliation:

1. Center of Neurology and Headache of Piauí, Teresina, Brazil

2. Botica Pharmacies, Teresina, Brazil

3. Santo Agostinho College, Teresina, Brazil

4. Department of Neurology, Universidade Federal do Piauí, Teresina, Brazil

Publisher

Informa UK Limited

Subject

Nutrition and Dietetics,General Medicine,General Neuroscience,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/1028415X.2016.1266133

Reference28 articles.